高级检索
当前位置: 首页 > 详情页

Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Univ Massachusetts, Ctr Personalized Canc Therapy, Boston, MA 02125 USA [2]Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA [3]Beth Israel Deaconess Med Ctr, Ctr Canc, Boston, MA 02215 USA [4]Harvard Med Sch, Boston, MA 02215 USA [5]Chongqing Med Univ, Affiliated Hosp 2, Dept Orthoped, Chongqing 400010, Peoples R China [6]Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada [7]Tongji Hosp,Dept Urol,Wuhan 430030,Hubei,Peoples R China
出处:
ISSN:

摘要:
Although well characterized as a transcriptional activator that drives prostate cancer (PCa) growth, androgen receptor (AR) can function as a transcriptional repressor, and high-level androgens can suppress PCa proliferation. The molecular basis for this repression activity remains to be determined. Genes required for DNA replication are highly enriched among androgen-repressed genes, and AR is recruited to the majority of these genes, where it rapidly represses their transcription. This activity is enhanced in PCa cells expressing high AR levels and is mediated by recruitment of hypophosphorylated retinoblastoma protein (Rb). Significantly, AR also indirectly increases the expression of DNA replication genes through stimulatory effects on other metabolic genes with subsequent CDK activation and Rb hyperphosphorylation. In castration-resistant PCa cells, which are dependent on high-level AR expression, this anti-proliferative repression function might be exploited through treatment with androgen in combination with agents that suppress AR-driven metabolic functions or cell cycle progression.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 2 区 生物
小类 | 2 区 细胞生物学
最新[2025]版:
大类 | 1 区 生物学
小类 | 2 区 细胞生物学
JCR分区:
出版当年[2014]版:
Q1 CELL BIOLOGY
最新[2023]版:
Q1 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者单位: [1]Univ Massachusetts, Ctr Personalized Canc Therapy, Boston, MA 02125 USA [2]Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA [3]Beth Israel Deaconess Med Ctr, Ctr Canc, Boston, MA 02215 USA [4]Harvard Med Sch, Boston, MA 02215 USA
通讯作者:
通讯机构: [1]Univ Massachusetts, Ctr Personalized Canc Therapy, Boston, MA 02125 USA [2]Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA [3]Beth Israel Deaconess Med Ctr, Ctr Canc, Boston, MA 02215 USA [4]Harvard Med Sch, Boston, MA 02215 USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:432 今日访问量:1 总访问量:413 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)